Regenerative Med Cos. To Merge For $65M
Carmell said Thursday it will merge with fellow regenerative medicine company Axolotl for up to $140 million, including earnouts, in a deal steered by Goodwin Procter LLP and Doyen Sebesta & Poelma LLLP....To view the full article, register now.
Already a subscriber? Click here to view full article